Kiora Pharmaceuticals Inc (KPRX): Next-Year EPS Estimate 61.28%
As of 2026-06-04, Kiora Pharmaceuticals Inc (KPRX) has a next-year EPS growth estimate of 61.28%.
On 2026-05-11, analyst consensus for KPRX's next-year EPS growth shifted from 60.90% to 61.28% — a positive change of 0.38 percentage points. The revised estimate has been sustained across 19 subsequent trading sessions. Current-year growth is projected at -0.76%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 61.28%
- EPS growth this year
- -0.76%
- EPS next quarter (est)
- -$0.47
- Last price
- $2.63
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 61.28% | -0.76% | -$0.47 | $2.63 |
| 2026-06-03 | 61.28% | -0.76% | -$0.47 | $2.68 |
| 2026-06-02 | 61.28% | -0.76% | -$0.47 | $2.72 |
| 2026-06-01 | 61.28% | -0.76% | -$0.47 | $2.81 |
| 2026-05-31 | 61.28% | -0.76% | -$0.47 | $2.68 |
| 2026-05-28 | 61.28% | -0.76% | -$0.47 | $2.83 |
| 2026-05-27 | 61.28% | -0.76% | -$0.47 | $2.79 |
| 2026-05-26 | 61.28% | -0.76% | -$0.47 | $2.70 |
| 2026-05-25 | 61.28% | -0.76% | -$0.47 | $2.56 |
| 2026-05-24 | 61.28% | -0.76% | -$0.47 | $2.56 |
| 2026-05-21 | 61.28% | -0.76% | -$0.47 | $2.68 |
| 2026-05-20 | 61.28% | -0.76% | -$0.47 | $2.64 |
| 2026-05-19 | 61.28% | -0.76% | -$0.47 | $2.52 |
| 2026-05-18 | 61.28% | -0.76% | -$0.47 | $2.51 |
| 2026-05-17 | 61.28% | -0.76% | -$0.47 | $2.50 |
| 2026-05-14 | 61.28% | -0.76% | -$0.47 | $2.58 |
| 2026-05-13 | 61.28% | -0.76% | -$0.47 | $2.62 |
| 2026-05-12 | 61.28% | -0.76% | -$0.58 | $2.44 |
| 2026-05-11 | 61.28% | -0.76% | -$0.58 | $2.41 |
| 2026-05-10 | 60.90% | -9.47% | -$0.71 | $2.45 |
| 2026-05-07 | 60.90% | -9.47% | -$0.71 | $2.45 |
| 2026-05-06 | 60.90% | -9.47% | -$0.71 | $2.51 |
| 2026-05-05 | 60.90% | -9.47% | -$0.71 | $2.51 |
| 2026-05-04 | 60.90% | -9.47% | -$0.71 | $2.54 |
| 2026-05-03 | 60.90% | -9.47% | -$0.71 | $2.44 |
| 2026-04-30 | 60.90% | -9.47% | -$0.71 | $2.35 |
| 2026-04-29 | 60.90% | -9.47% | -$0.71 | $2.35 |
| 2026-04-28 | 60.90% | -9.47% | -$0.71 | $2.33 |
| 2026-04-27 | 60.90% | -9.47% | -$0.71 | $2.32 |
| 2026-04-26 | 60.90% | -9.47% | -$0.71 | $2.35 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Kiora Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Kiora Pharmaceuticals Inc (KPRX) has a next-year EPS growth estimate of 61.28%, based on analyst consensus.
When was the latest EPS estimate revision for KPRX?▾
The most recent revision occurred on 2026-05-11, when analysts adjusted the next-year EPS growth estimate from 60.90% to 61.28%.
What sector and industry does Kiora Pharmaceuticals Inc belong to?▾
Kiora Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. KPRX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Kiora Pharmaceuticals Inc (KPRX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports